213 related articles for article (PubMed ID: 38001266)
1. Noradrenergic regulation of cue-guided decision making and impulsivity is doubly dissociable across frontal brain regions.
Chernoff CS; Hynes TJ; Schumacher JD; Ramaiah S; Avramidis DK; Mortazavi L; Floresco SB; Winstanley CA
Psychopharmacology (Berl); 2024 Apr; 241(4):767-783. PubMed ID: 38001266
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic contributions to cue-driven risk-taking and impulsivity.
Chernoff CS; Hynes TJ; Winstanley CA
Psychopharmacology (Berl); 2021 Jul; 238(7):1765-1779. PubMed ID: 33649970
[TBL] [Abstract][Full Text] [Related]
3. Serotonin 2C Antagonism in the Lateral Orbitofrontal Cortex Ameliorates Cue-Enhanced Risk Preference and Restores Sensitivity to Reinforcer Devaluation in Male Rats.
Hathaway BA; Schumacher JD; Hrelja KM; Winstanley CA
eNeuro; 2021; 8(6):. PubMed ID: 34815296
[TBL] [Abstract][Full Text] [Related]
4. Differential roles for cortical versus sub-cortical noradrenaline and modulation of impulsivity in the rat.
Benn A; Robinson ES
Psychopharmacology (Berl); 2017 Jan; 234(2):255-266. PubMed ID: 27744551
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evidence of a cholinergic contribution to elevated impulsivity and risky decision-making caused by adding win-paired cues to a rat gambling task.
Betts GD; Hynes TJ; Winstanley CA
J Psychopharmacol; 2021 Jun; 35(6):701-712. PubMed ID: 33573446
[TBL] [Abstract][Full Text] [Related]
6. Chronic atomoxetine treatment during adolescence does not influence decision-making on a rodent gambling task, but does modulate amphetamine's effect on impulsive action in adulthood.
Silveira MM; Murch WS; Clark L; Winstanley CA
Behav Pharmacol; 2016 Jun; 27(4):350-63. PubMed ID: 26650252
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of guanfacine improves food-motivated impulsive choice behavior primarily via direct stimulation of postsynaptic α
Nishitomi K; Yano K; Kobayashi M; Jino K; Kano T; Horiguchi N; Shinohara S; Hasegawa M
Behav Brain Res; 2018 Jun; 345():21-29. PubMed ID: 29476896
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in noradrenergic modulation of attention and impulsivity in rats.
Mei X; Wang L; Yang B; Li X
Psychopharmacology (Berl); 2021 Aug; 238(8):2167-2177. PubMed ID: 33834255
[TBL] [Abstract][Full Text] [Related]
9. D
Mortazavi L; Hynes TJ; Chernoff CS; Ramaiah S; Brodie HG; Russell B; Hathaway BA; Kaur S; Winstanley CA
J Neurosci; 2023 Feb; 43(6):979-992. PubMed ID: 36623876
[TBL] [Abstract][Full Text] [Related]
10. Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists.
Fernando AB; Economidou D; Theobald DE; Zou MF; Newman AH; Spoelder M; Caprioli D; Moreno M; Hipólito L; Aspinall AT; Robbins TW; Dalley JW
Psychopharmacology (Berl); 2012 Jan; 219(2):341-52. PubMed ID: 21761147
[TBL] [Abstract][Full Text] [Related]
11. Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex.
Sun H; Cocker PJ; Zeeb FD; Winstanley CA
Psychopharmacology (Berl); 2012 Jan; 219(2):285-301. PubMed ID: 21809008
[TBL] [Abstract][Full Text] [Related]
12. Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle.
Liu YP; Huang TS; Tung CS; Lin CC
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():81-90. PubMed ID: 25151304
[TBL] [Abstract][Full Text] [Related]
13. Atomoxetine restores the response inhibition network in Parkinson's disease.
Rae CL; Nombela C; Rodríguez PV; Ye Z; Hughes LE; Jones PS; Ham T; Rittman T; Coyle-Gilchrist I; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
Brain; 2016 Aug; 139(Pt 8):2235-48. PubMed ID: 27343257
[TBL] [Abstract][Full Text] [Related]
14. Increased motor impulsivity in a rat gambling task during chronic ropinirole treatment: potentiation by win-paired audiovisual cues.
Tremblay M; Barrus MM; Cocker PJ; Baunez C; Winstanley CA
Psychopharmacology (Berl); 2019 Jun; 236(6):1901-1915. PubMed ID: 30706098
[TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of d-amphetamine and atomoxetine on measures of impulsive action and choice.
Higgins GA; Brown M; MacMillan C; Silenieks LB; Thevarkunnel S
Pharmacol Biochem Behav; 2021 Aug; 207():173220. PubMed ID: 34175329
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous blockade of dopamine and noradrenaline reuptake promotes disadvantageous decision making in a rat gambling task.
Baarendse PJ; Winstanley CA; Vanderschuren LJ
Psychopharmacology (Berl); 2013 Feb; 225(3):719-31. PubMed ID: 22968659
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D3 Receptors Modulate the Ability of Win-Paired Cues to Increase Risky Choice in a Rat Gambling Task.
Barrus MM; Winstanley CA
J Neurosci; 2016 Jan; 36(3):785-94. PubMed ID: 26791209
[TBL] [Abstract][Full Text] [Related]
18. Noradrenaline reuptake inhibition increases control of impulsive action by activating D
Sasamori H; Ohmura Y; Yoshida T; Yoshioka M
Eur J Pharmacol; 2019 Feb; 844():17-25. PubMed ID: 30503361
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
Bradshaw SE; Agster KL; Waterhouse BD; McGaughy JA
Brain Res; 2016 Jun; 1641(Pt B):245-57. PubMed ID: 26774596
[TBL] [Abstract][Full Text] [Related]
20. Noradrenergic modulation of risk/reward decision making.
Montes DR; Stopper CM; Floresco SB
Psychopharmacology (Berl); 2015 Aug; 232(15):2681-96. PubMed ID: 25761840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
